INDICATIONS AND USAGE
Teczifuma is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
DOSAGE AND ADMINISTRATION
Starting dose: 120 mg twice a day, orally, for 7 days.
Maintenance dose after 7 days: 240 mg twice a day, orally with or without food.
DOSAGE FORMS AND STRENGTHS
Enteric-coated capsules: 120 mg and 240 mg.
STORAGE OF TECZIFUMA
Keep Teczifuma at room temperature (up to 30°C).